Potrero Medical, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Potrero Medical, Inc. - overview
Established
2011
Location
Hayward, CA, US
Primary Industry
Medical Devices & Equipment
About
Potrero Medical, Inc. is a healthcare technology company focused on innovative critical care solutions, particularly through advanced monitoring systems to improve patient outcomes in hospitals. Founded in 2011, Potrero Medical, Inc. is headquartered in Hayward, US and specializes in critical care monitoring solutions.
The company raised USD 5. 44 mn in Series C funding on October 29, 2019, reaching a total amount raised of USD 5. 44 mn and a current valuation of USD 108. 96 mn.
The founders are Adam S. and Daniel Burnett, with Ann An serving as the CEO. No major pivots or subsidiaries have been documented. Potrero Medical specializes in advanced critical care solutions through its flagship Accuryn® Monitoring System.
This system transforms traditional Foley catheters into smart devices for real-time monitoring of urinary output and intra-abdominal pressure, aimed at detecting acute kidney injury and catheter-associated urinary tract infections. It primarily serves hospitals, especially burn and pediatric centers, with a focus on the US market and potential international expansion. Potrero Medical generates revenue through direct sales of its Accuryn® Monitoring System and related training and support services to healthcare institutions. Transactions involve B2B sales where monitoring systems are integrated as capital equipment, incorporating various payment structures including one-time purchases and leasing agreements.
The pricing strategy emphasizes the value provided by real-time monitoring capabilities to improve outcomes in critical care settings. Potrero Medical plans to leverage its recent funding of USD 5. 44 mn from the Series C round to support initiatives including the development of new products and expansion into additional markets. The company is focused on designing advanced monitoring solutions, targeting release dates in the near future, and plans to expand its reach within international markets, enhancing its global presence.
These efforts aim to improve patient care in critical environments, particularly addressing issues like acute kidney injury.
Current Investors
GT Healthcare Capital Partners, Sunder Capital, Green Park & Golf Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment, Hardware
Website
www.potreromed.com
Company Stage
Series C
Total Amount Raised
Subscriber access only
Potrero Medical, Inc. - employee data

Potrero Medical, Inc. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.